HeartSciences (HSCS) announced that the University of the West of England, UWE, has adopted the Company’s MyoVista Insights platform and MyoVista wavECG device as its exclusive ECG technologies to establish a Reference Center for ECG Education and Technology. Under the agreement, MyoVista Insights and the MyoVista wavECG device will be used exclusively across UWE’s cardiac and physiological science teaching programs to train the next generation of cardiac scientists.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSCS:
- HeartSciences MyoVista Insights selected by Cibolo Rural Health Networks
- HeartSciences Secures New Private Financing Through Note Issuance
- Heart Test Laboratories: AI-Driven Cardiology Platform Nearing Regulatory Milestones Supports Upside and Buy Rating
- Heart Test Laboratories Approves Indemnification Agreement
- HeartSciences announces FDA 510(k) submission for MyoVista wavECG